Transcriptomic analysis of A3250 inflammatory breast cancer (IBC) cells, SUM149 IBC and MDA-MB-231 non-IBC cells. Transcriptomic analysis of A3250 inflammatory breast cancer (IBC) cells, SUM149 IBC and MDA-MB-231 non-IBC cells

Purpose: Transcriptome profiling (RNA-seq) of a novel human Inflammatory Breast Cancer cell line A3250 in comparison to SUM149 and MDA-MB-231 Inflammatory Breast Cancer (IBC) is the most aggressive form of breast cancer with distinct clinical and histopathological features, but understanding of the unique aspects of IBC biology lags far behind that of other breast cancers. We describe a novel triple-negative IBC cell line, A3250, that recapitulates key features of human IBC in a mouse xenograft model.The purpose of this study was to compare differences in gene expression between A3250 IBC, MDA-MB-231 non-IBC and SUM149 IBC that does not present with typical clinical sympotms of IBC in a mouse model, with the goal of identifying unique molecular features for this unique type of breast cancer Results: RNA-Seq analysis identified expression profile characteristic for the novel A3250 IBC cell line, compared to SUM149 IBC and MDA-MB-231 non-IBC. Overall design: RNA-Seq analysis of A3250 IBC tumor cells (n=3), SUM149 IBC tumor cells (n=3) and MDA-MB-231 non-IBC tumor cells (n=3) cultured in vitro.

研究目的：对新型人炎性乳腺癌（Inflammatory Breast Cancer, IBC）细胞系A3250开展转录组测序（RNA-seq）分析，并与SUM149及MDA-MB-231进行对比。炎性乳腺癌是侵袭性最强的乳腺癌亚型，具有独特的临床与组织病理学特征，但目前学界对其生物学特性的认知远落后于其他乳腺癌亚型。本研究报道一株新型三阴性炎性乳腺癌细胞系A3250，该细胞系可在小鼠异种移植模型中重现人炎性乳腺癌的关键表型。本研究旨在通过小鼠模型，对比A3250 IBC、MDA-MB-231非IBC与无典型IBC临床症状的SUM149 IBC之间的基因表达差异，以期鉴定这类特殊乳腺癌的独特分子特征。
研究结果：与SUM149 IBC及MDA-MB-231非IBC相比，RNA-seq分析明确了新型A3250 IBC细胞系的特征性表达谱。
整体实验设计：对体外培养的A3250 IBC肿瘤细胞（n=3）、SUM149 IBC肿瘤细胞（n=3）及MDA-MB-231非IBC肿瘤细胞（n=3）开展RNA-seq分析。